PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-03-05

Date Title Company
05-Mar-2024 NX Development Corp. is Granted Orphan-Drug Designation Status by US FDA for Gleolan® in Ovarian and Related Cancers Newswire
05-Mar-2024 NX Development Corp. is Granted Orphan-Drug Designation Status by US FDA for Gleolan(R) in Ovarian and Related Cancers AccessWire
05-Mar-2024 Cantargia Reports New Preclinical Data on Antitumor Effects of Nadunolimab in Pancreatic Cancer AccessWire
05-Mar-2024 Avenues Expands Its Services to Colorado AccessWire
05-Mar-2024 InDevR Launches Expert Services to Address Vaccine Development Challenges AccessWire
05-Mar-2024 ADARE PHARMA SOLUTIONS TO EXPAND PACKAGING & WAREHOUSING CAPABILITIES IN EUROPE Adare Pharma Solutions
05-Mar-2024 The York Health Economic Consortium will undertake the first UK health economic analysis of Ondine’s Steriwave light-activated antimicrobial to reduce Surgical Site Infections York Health Economics Consortium (YHEC)
05-Mar-2024 Ariceum Therapeutics announces opening of new state-of-the-art laboratory in Berlin providing infrastructure for radiopharmaceutical development activities Ariceum Therapeutics
05-Mar-2024 Fibrocor Therapeutics enters into research and development collaboration with McQuade Center for Strategic Research and Development to advance Alport Syndrome program Fibrocor Therapeutics Inc
05-Mar-2024 Alcidion launches Miya Results Tracking in response to patient safety challenge Alcidion Group Limited
05-Mar-2024 Transgene, NEC and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050 Transgene
05-Mar-2024 AlzeCure publishes clinical results supporting continued development of NeuroRestore ACD856 against Alzheimer's AlzeCure Pharma AB
05-Mar-2024 Lundbeck presents encouraging results from the Lu AF82422 trial for Multiple System Atrophy at the international AD/PD 2024 conference on neurodegenerative disorders Lundbeck A/S
05-Mar-2024 Lantern Pharma's A.I. Platform, RADR®, Surpasses 60 Billion Data Points – Anticipates Reaching 100 Billion Data Points in 2024, Paving the Way for Enhanced Cancer Therapy Innovations and Expedited Development Timelines Lantern Pharma
05-Mar-2024 ViiV Healthcare presents phase I clinical trial findings of a cabotegravir long-acting injectable investigational formulation allowing at least four months between doses ViiV Healthcare
05-Mar-2024 My Quest Story - Allan Mendez AccessWire
05-Mar-2024 Enliven Home Infusion Specialists Achieves 200% Revenue Growth Through Cutting-Edge Technology from AlayaCare AccessWire
05-Mar-2024 CluePoints’ Audit Trail Review Project Wins Award for Innovation in the Management of Clinical Data Award CluePoints
05-Mar-2024 Early Bird Ends March 8 for Pharma CI Europe, PMRC Pharma CI Conference
05-Mar-2024 assisTek Celebrates 25 Years of Pioneering Innovation in eClinical Patient Data for Clinical Research Trials Newswire